The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)

Open-label, Non Placebo-Controlled Study To Verify the Effect of Sitagliptin In Adult Patients With Type 2 Diabetes and Inadequate Glycemic Control

to assess the effect of treatment with Sitagliptin (MK0431) on HbA1c (Hemoglobin A1c) and the safety and tolerability of Sitagliptin.

Inclusion Criteria:

• Patients Who Are 18 Years Of Age With Type 2 Diabetes Mellitus Who Are Either:

  • Not On Antihyperglycemic (AHa) Medication (Off For At Least 2 Months)
  • Or On A Single AHa